Back to the complete issue
Monday, 12 April 2021

Questions about Sinovac, Sinopharm protection rates

Sinopharm and Sinovac — two vaccines Egypt is relying on in its inoculation drive — “don’t have very high protection rates” against the virus the causes covid-19, director of the China Centers for Disease Control Gao Fu said at a presser, according to the Associated Press reports. The country’s top disease control body is now considering the use of different vaccines with different “technical lines” and is also mulling mixing its existing jabs to make them more effective, Gao added.

The Sinovac shot, of which Egypt plans to produce 80 mn doses each year through state-owned Vacsera, is well below the Sinopharm jab's efficacy rate: Sinovac was reportedly found to be just 50.4% effective at preventing symptomatic infections in a Brazilian trial earlier this year — barely meeting the threshold for regulatory approval and much lower than the initially reported efficacy rate. Egypt has so far received 680k doses of Sinopharm and is expected to get its hands on an additional 900k-1 mn doses of the jab in the coming days. Sinopharm has claimed a 79% efficacy rate.

Next in line for jabs here at home: MPs, who are expected to get vaccinated this week after Prime Minister Moustafa Madbouly signed off on their eligibility, along with their immediate families, Parliamentary Affairs Minister Alaa Fouad said during a plenary session yesterday, Masrawy reports. Rep. Mostafa Bakry had previously proposed that the entire House of Representatives go on recess until members are inoculated, after 15 MPs were infected.

The Health Ministry reported 812 new covid-19 infections yesterday, up from 801 the day before. Egypt has now disclosed a total of 210,489 confirmed cases of covid-19. The ministry also reported 40 new deaths, bringing the country’s total death toll to 12,445.

Saudi Arabia will allow (limited) Ramadan-evening Taraweeh prayers in the two Grand Mosques in Mecca and Medina, according to a statement. The Taraweeh prayers in the two mosques will be capped to five Tasleemat, with strict precautionary measures in place to curb the spread of covid-19, the statement said.

Pfizer and BioNTech’s covid-19 vaccine could be less effective against the South Africa variant than previously thought, according to the real-world study in Israel that allowed the country to roll out its vaccination program at record speed. The study — the results of which may not be properly indicative because of the small sample size and other limitations — found the prevalence of the variant to be eight times higher in vaccinated than unvaccinated people, Reuters reports. “This means that the South African variant is able, to some extent, to break through the vaccine’s protection,” Tel Aviv University professor Adi Stern said.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.